Primary Site >> Colorectal Cancer
Gene >> CHPT1
| 1. | |||||||||||
| Journal: | Biochemistry. 1995 May 30;34(21):7200-6. | ||||||||||
| Title: | Differential stabilization of eukaryotic DNA topoisomerase I cleavable complexes by camptothecin derivatives. | ||||||||||
| Author: | Tanizawa, A|Kohn, K W|Kohlhagen, G|Leteurtre, F|Pommier, Y | ||||||||||
| PMID: | 7766631 | ||||||||||
| 2. | |||||||||||
| Journal: | Ann N Y Acad Sci. 1996 Dec 13;803:292-305. | ||||||||||
| Title: | Clinical trials of irinotecan hydrochloride (CPT, campto injection, topotecin injection) in Japan. | ||||||||||
| Author: | Saijo, N | ||||||||||
| PMID: | 8993523 | ||||||||||
| 3. | |||||||||||
| Journal: | Cancer Res. 1999 Jun 15;59(12):2939-43. | ||||||||||
| Title: | Homocamptothecin, an E-ring modified camptothecin with enhanced lactone stability, retains topoisomerase I-targeted activity and antitumor properties. | ||||||||||
| Author: | Lesueur-Ginot, L|Demarquay, D|Kiss, R|Kasprzyk, P G|Dassonneville, L|Bailly, C|Camara, J|Lavergne, O|Bigg, D C | ||||||||||
| PMID: | 10383158 | ||||||||||
| 4. | |||||||||||
| Journal: | Anticancer Drug Des. 2001 Feb;16(1):27-36. | ||||||||||
| Title: | A novel B-ring modified homocamptothecin, 12-Cl-hCPT, showing antiproliferative and topoisomerase I inhibitory activities superior to SN-38. | ||||||||||
| Author: | Bailly, C|Laine, W|Baldeyrou, B|Demarquay, D|Huchet, M|Coulomb, H|Lanco, C|Lavergne, O|Bigg, D C | ||||||||||
| PMID: | 11762642 | ||||||||||
| 5. | |||||||||||
| Journal: | Int J Oncol. 2002 Apr;20(4):855-63. | ||||||||||
| Title: | Ceramide involvement in homocamptothecin- and camptothecin-induced cytotoxicity and apoptosis in colon HT29 cells. | ||||||||||
| Author: | Chauvier, David|Morjani, Hamid|Manfait, Michel | ||||||||||
| PMID: | 11894136 | ||||||||||
| 6. | |||||||||||
| Journal: | Anticancer Drugs. 2004 Oct;15(9):899-906. | ||||||||||
| Title: | Cytotoxic effect of different camptothecin formulations on human colon carcinoma in vitro. | ||||||||||
| Author: | Saetern, Ann Mari|Brandl, Martin|Bakkelund, Wenche H|Sveinbjornsson, Baldur | ||||||||||
| PMID: | 15457131 | ||||||||||
| 7. | |||||||||||
| Journal: | Gan To Kagaku Ryoho. 2008 Sep;35(9):1583-6. | ||||||||||
| Title: | [Three cases with liver metastasis from gastric or colon cancer successfully treated with S-1 combined with CPT- 11]. | ||||||||||
| Author: | Mazaki, Takero|Mado, Kazunari|Manmoto, Jun|Okame, Hirohisa|Ishii, Yukimoto|Suzuki, Kazuyoshi|Masuda, Hideki|Takayama, Tadatoshi | ||||||||||
| PMID: | 18799916 | ||||||||||
| 8. | |||||||||||
| Journal: | Biochem Pharmacol. 2010 Apr 15;79(8):1100-7. | ||||||||||
| Title: | Moxifloxacin increases anti-tumor and anti-angiogenic activity of irinotecan in human xenograft tumors. | ||||||||||
| Author: | Reuveni, Debby|Halperin, Drora|Fabian, Ina|Tsarfaty, Galia|Askenasy, Nadir|Shalit, Itamar | ||||||||||
| PMID: | 20025849 | ||||||||||
| 9. | |||||||||||
| Journal: | Biosci Rep. 2011 Oct;31(5):363-9. | ||||||||||
| Title: | RECQL5 is an important determinant for camptothecin tolerance in human colorectal cancer cells. | ||||||||||
| Author: | Wang, Xiaoqi|Lu, Xincheng|Zhou, Guangjin|Lou, Hua|Luo, Guangbin | ||||||||||
| PMID: | 21210765 | ||||||||||
| 10. | |||||||||||
| Journal: | J Control Release. 2011 Dec 10;156(2):246-57. | ||||||||||
| Title: | Surface-modified silica nanoparticles for tumor-targeted delivery of camptothecin and its biological evaluation. | ||||||||||
| Author: | Botella, Pablo|Abasolo, Ibane|Fernandez, Yolanda|Muniesa, Carlos|Miranda, Sonia|Quesada, Manuel|Ruiz, Jorge|Schwartz, Simo Jr|Corma, Avelino | ||||||||||
| PMID: | 21756949 | ||||||||||